Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications
Study Details
Study Description
Brief Summary
Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al in 2018. It was developed by the Metabolic Research Disease Unit at the Institute National de Ciencias Médicas Salvador Zubirán and validated against the euglycemic hyperinsulinemic clamp and the frequently-sampled intravenous glucose tolerance test in Mexican population.It is a non-insulin-based alternative to insulin-based methods to quantify peripheral insulin sensitivity and an alternative to the Homeostatic Model Assessment (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI).
Very limited research correlate between visceral obesity and microvascular complications in type 2 diabetic patients and how can the metabolic score for insulin resistance predict visceral obesity and microvascular complications in type2 diabetic patients. In this study the investigators will search for these correlations.
Study Design
Outcome Measures
Primary Outcome Measures
- correlation between METS IR and visceral fat in type 2 diabetes [one year]
Study the cor relation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication
Eligibility Criteria
Criteria
Inclusion Criteria:
- Age > 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study
Exclusion Criteria:
- Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mahmoud Soliman | Sohag | Egypt | 00000 |
Sponsors and Collaborators
- Sohag University
Investigators
- Study Director: mahmoud soliman, Sohag University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Soh-Med-23-10-13MD